| |
| |
|
| Insider
Information: |
Molineaux Susan |
| Relationship: |
Director |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
14,552 |
|
|
Indirect Shares
|
204,875 |
|
|
| Direct
Value |
$89,726 |
|
|
|
Indirect Value
|
$871,159 |
|
|
| Total
Shares |
219,427 |
|
|
| Total
Value |
$960,885 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -80.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Geron Corporation |
GERN |
Director |
2023-05-01 |
0 |
2023-12-29 |
130,527 |
Premium* |
|
|
Calithera Biosciences, Inc. |
CALA |
PRESIDENT & CEO, Direc... |
2023-01-23 |
4,724 |
2023-01-23 |
33,142 |
Premium* |
|
|
Theravance Biopharma, Inc. |
TBPH |
Director |
2021-04-27 |
9,828 |
2021-04-27 |
41,206 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GERN |
Geron Corporation |
Director |
– • – |
2023-12-29 |
4 |
A |
$0.00 |
$0 |
I/I |
6,220 |
130,527 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2023-09-29 |
4 |
A |
$0.00 |
$0 |
I/I |
6,191 |
124,307 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2023-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
4,088 |
118,116 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2023-05-01 |
4 |
AS |
$2.48 |
$86,800 |
D/D |
(35,000) |
0 |
0 |
% |
|
| GERN |
Geron Corporation |
Director |
– • – |
2023-05-01 |
4 |
OE |
$1.10 |
$38,500 |
D/D |
35,000 |
35,000 |
0 |
- |
|
| CALA |
Calithera Biosciences, In... |
PRESIDENT & CEO |
• • – |
2023-01-23 |
4 |
D |
$0.45 |
$235 |
I/I |
(526) |
27,859 |
0 |
- |
|
| CALA |
Calithera Biosciences, In... |
PRESIDENT & CEO |
• • – |
2021-11-10 |
4 |
B |
$0.85 |
$84,670 |
I/I |
100,000 |
557,188 |
2.66 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2021-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
9,828 |
9,828 |
0 |
- |
|
| CALA |
Calithera Biosciences, In... |
PRESIDENT & CEO |
• • – |
2021-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
85,000 |
95,000 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2020-04-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,635 |
6,635 |
0 |
- |
|
| CALA |
Calithera Biosciences, In... |
PRESIDENT AND CEO |
• • – |
2019-06-25 |
4 |
B |
$3.88 |
$200,208 |
I/I |
51,600 |
457,188 |
2.66 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2019-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,385 |
8,385 |
0 |
- |
|
| CALA |
Calithera Biosciences, In... |
PRESIDENT AND CEO |
• • – |
2019-02-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
12,986 |
395,588 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2018-12-31 |
4 |
A |
$0.00 |
$0 |
I/I |
13,125 |
107,980 |
0 |
- |
|
| CALA |
Calithera Biosciences, In... |
PRESIDENT AND CEO |
• • – |
2018-11-14 |
4 |
GD |
$0.00 |
$0 |
I/I |
6,476 |
408,574 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2018-09-28 |
4 |
A |
$0.00 |
$0 |
I/I |
7,457 |
94,855 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2018-06-29 |
4 |
A |
$0.00 |
$0 |
I/I |
3,827 |
87,398 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2018-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,186 |
14,186 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2018-03-29 |
4 |
A |
$0.00 |
$0 |
I/I |
3,088 |
83,571 |
0 |
- |
|
| CALA |
Calithera Biosciences, In... |
PRESIDENT AND CEO |
• • – |
2018-03-02 |
4 |
OE |
$2.64 |
$71,259 |
D/D |
26,992 |
44,860 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2017-12-29 |
4 |
A |
$0.00 |
$0 |
I/I |
7,292 |
80,483 |
0 |
- |
|
| CALA |
Calithera Biosciences, In... |
PRESIDENT AND CEO |
• • – |
2017-12-05 |
4 |
OE |
$0.96 |
$21,257 |
D/D |
12,868 |
15,368 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2017-09-29 |
4 |
A |
$0.00 |
$0 |
I/I |
6,021 |
73,191 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2017-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
4,738 |
67,170 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Director |
– • – |
2017-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
12,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
